Skip to content
2000
Volume 24, Issue 2
  • ISSN: 1570-159X
  • E-ISSN: 1875-6190

Abstract

Background

The growing prevalence of neuropsychiatric disorders is becoming a major health challenge. Traditional pharmacotherapies face limitations, making drug repurposing a valuable strategy. However, high-throughput screening approaches for these conditions are scarce.

Methods

This study leveraged exposure data from the UK Biobank Neale Lab (N = 361,141) and outcome data from the FinnGen database (N = approximately 410,000) to employ Mendelian Randomization (MR) analyses and identify potential drug repurposing candidates for neuropsychiatric disorders. Sensitivity, Linkage Disequilibrium Score Correlation (LDSC), and Bayesian Colocalization (COLOC) analyses were conducted to ensure the robustness and reliability of our findings.

Results

Using the IVW method, seven medications with negative causal associations with neuropsychiatric disorders were identified. Pregabalin, bumetanide, and prednisolone were associated with reduced anxiety (beta = -7.28, = 4.00e-03; beta = -2.24, = 6.00e-03; beta = -1.74, = 2.84e-03). Vitamin B preparations showed an inverse association with dementia (beta = -2.47, = 1.51e-03), Creon E/C granules with epilepsy (beta = -4.99, = 3.91e-03), Pentasa SR 250 mg with multiple sclerosis (beta = -3.95, = 3.83e-03), and zolmitriptan with stroke excluding subarachnoid hemorrhage (beta = -1.61, = 6.00e-03). Sensitivity analyses confirmed these findings, whereas the LDSC and COLOC analyses provided additional support.

Conclusion

MR-based drug repurposing is a promising approach for the treatment of neuropsychiatric disorders. Further validation is necessary to effectively integrate these medications into clinical practice.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cn/10.2174/011570159X368382250527073353
2026-06-10
2026-02-27

  • From This Site

    /content/journals/cn/10.2174/011570159X368382250527073353
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SteinmetzJ.D. SeeherK.M. SchiessN. NicholsE. CaoB. ServiliC. CavalleraV. CousinE. HaginsH. MobergM.E. MehlmanM.L. AbateY.H. AbbasJ. AbbasiM.A. AbbasianM. AbbastabarH. AbdelmassehM. AbdollahiM. AbdollahiM. AbdollahifarM-A. Abd-RabuR. AbdulahD.M. AbdullahiA. AbediA. AbediV. Abeldańo ZuńigaR.A. AbidiH. AbiodunO. AboagyeR.G. AbolhassaniH. AboyansV. AbrhaW.A. AbualhasanA. Abu-GharbiehE. AburuzS. AdamuL.H. AddoI.Y. AdebayoO.M. AdekanmbiV. AdekiyaT.A. AdikusumaW. AdnaniQ.E.S. AdraS. AfeworkT. AfolabiA.A. AfrazA. AfzalS. AghamiriS. AgodiA. Agyemang-DuahW. AhinkorahB.O. AhmadA. AhmadD. AhmadS. AhmadzadeA.M. AhmedA. AhmedA. AhmedH. AhmedJ.Q. AhmedL.A. AhmedM.B. AhmedS.A. AjamiM. AjiB. AjumobiO. AkadeS.E. AkbariM. AkbarialiabadH. AkhlaghiS. AkinosoglouK. AkinyemiR.O. AkondeM. Al HasanS.M. AlahdabF. AL-AhdalT.M.A. Al-amerR.M. AlbashtawyM. AlBatainehM.T. AldawsariK.A. AlemiH. AlemiS. AlgammalA.M. Al-GheethiA.A.S. AlhalaiqaF.A.N. AlhassanR.K. AliA. AliE.A. AliL. AliM.U. AliM.M. AliR. AliS. AliS.S.S. AliZ. AlifS.M. AlimohamadiY. AliyiA.A. AljofanM. AljunidS.M. AlladiS. AlmazanJ.U. AlmustanyirS. Al-OmariB. AlqahtaniJ.S. AlqasmiI. AlqutaibiA.Y. Al-Shahi SalmanR. AltaanyZ. Al-TawfiqJ.A. AltirkawiK.A. Alvis-GuzmanN. Al-WorafiY.M. AlyH. AlyS. AlzoubiK.H. AmaniR. AmindarolzarbiA. AmiriS. Amirzade-IranaqM.H. AmuH. AmugsiD.A. AmusaG.A. AmzatJ. AncuceanuR. AnderliniD. AndersonD.B. AndreiC.L. AndroudiS. AngappanD. AngesomT.W. AnilA. Ansari-MoghaddamA. AnwerR. ArafatM. AravkinA.Y. AredaD. AriffinH. ArifinH. ArkewM. ÄrnlövJ. AroojM. ArtamonovA.A. ArtantiK.D. ArulebaR.T. Asadi-PooyaA.A. AsenaT.F. Asghari-JafarabadiM. AshrafM. AshrafT. AtalellK.A. AthariS.S. AtinafuB.T.T. AtorkeyP. AtoutM.M.W. AtreyaA. AujayebA. AvanA. Ayala QuintanillaB.P. AyatollahiH. AyindeO.O. AyyoubzadehS.M. AzadnajafabadS. AziziZ. AzizianK. AzzamA.Y. BabaeiM. BadarM. BadiyeA.D. BaghdadiS. BagheriehS. BaiR. BaigA.A. BalakrishnanS. BalallaS. BaltatuO.C. BanachM. BandyopadhyayS. BanerjeeI. BaranM.F. BarbozaM.A. BarchittaM. BardhanM. Barker-ColloS.L. BärnighausenT.W. BarrowA. BashashD. BashiriH. BashiruH.A. BasiruA. BassoJ.D. BasuS. BatihaA-M.M. BatraK. BauneB.T. BediN. BegdeA. BegumT. BehnamB. BehnoushA.H. BeiranvandM. BéjotY. BekeleA. BeleteM.A. BelgaumiU.I. BemanalizadehM. BenderR.G. BenforB. BennettD.A. BensenorI.M. BericeB. BettencourtP.J.G. BeyeneK.A. BhadraA. BhagatD.S. BhangdiaK. BhardwajN. BhardwajP. BhargavaA. BhaskarS. BhatA.N. BhatV. BhattiG.K. BhattiJ.S. BhattiR. BijaniA. BikbovB. BilalagaM.M. BiswasA. BitarafS. BitraV.R. BjørgeT. BodolicaV. BodunrinA.O. BoloorA. BraithwaiteD. BrayneC. BrennerH. BrikoA. Bringas VegaM.L. BrownJ. BudkeC.M. BuonsensoD. BurkartK. BurnsR.A. BustanjiY. ButtM.H. ButtN.S. ButtZ.A. CabralL.S. Caetano dos SantosF.L. CalinaD. Campos-NonatoI.R. CaoC. CarabinH. CárdenasR. CarrerasG. CarvalhoA.F. Castańeda-OrjuelaC.A. CasulliA. Catalá-LópezF. CatapanoA.L. CayeA. CegolonL. CenderadewiM. CerinE. Chacón-UscamaitaP.R. ChanJ.S.K. ChanieG.S. CharanJ. ChattuV.K. Chekol AbebeE. ChenH. ChenJ. ChiG. ChichagiF. ChidambaramS.B. ChimoriyaR. ChingP.R. ChitheerA. ChongY.Y. ChopraH. ChoudhariS.G. ChowdhuryE.K. ChowdhuryR. ChristensenH. ChuD-T. ChukwuI.S. ChungE. CoberlyK. ColumbusA. ComachioJ. CondeJ. CortesiP.A. CostaV.M. CoutoR.A.S. CriquiM.H. Cruz-MartinsN. Dabbagh OhadiM.A. DadanaS. DadrasO. DaiX. DaiZ. D’AmicoE. DanawiH.A. DandonaL. DandonaR. DarwishA.H. DasS. DasS. DascaluA.M. DashN.R. DashtiM. De la HozF.P. de la Torre-LuqueA. De LeoD. DeanF.E. DehghanA. DehghanA. DejeneH. DemantD. DemetriadesA.K. DemissieS. DengX. DesaiH.D. DevanbuV.G.C. DhamaK. DharmaratneS.D. DhimalM. Dias da SilvaD. DiazD. DibasM. DingD.D. DinuM. DiracM.A. DiressM. DoT.C. DoT.H.P. DoanK.D.K. DodangehM. DoheimM.F. DokovaK.G. DongarwarD. DsouzaH.L. DubeJ. DuraisamyS. DurojaiyeO.C. DuttaS. DziedzicA.M. EdinurH.A. EissazadeN. EkholuenetaleM. EkundayoT.C. El NahasN. El SayedI. ElahiN.M.A. ElbaraziI. ElemamN.M. ElgarF.J. ElgendyI.Y. ElhabashyH.R. ElhadiM. EliloL.T. EllenbogenR.G. ElmeligyO.A.A. ElmonemM.A. ElshaerM. ElsohabyI. EmamverdiM. EmetoT.I. EndresM. EsezoborC.I. EskandariehS. FadaeiA. FagbamigbeA.F. FahimA. FaramarziA. FaresJ. Farjoud KouhanjaniM. FaroA. FarzadfarF. FatehizadehA. FathiM. FathiS. FatimaS.A.F. FeizkhahA. FereshtehnejadS-M. FerrariA.J. FerreiraN. FetensaG. FirouraghiN. FischerF. FonsecaA.C. ForceL.M. FornariA. ForoutanB. FukumotoT. GadanyaM.A. GaidhaneA.M. GalaliY. GalehdarN. GanQ. GandhiA.P. GanesanB. GardnerW.M. GargN. GauS-Y. GautamR.K. GebreT. GebrehiwotM. GebremeskelG.G. GebreslassieH.G. GetacherL. Ghaderi YazdiB. GhadirianF. GhaffarpasandF. GhanbariR. GhasemiM.R. GhazyR.M. GhimireS. GholamiA. GholamrezanezhadA. GhotbiE. GhozyS. GialluisiA. GillP.S. GlasstetterL.M. GnedovskayaE.V. GolchinA. GolechhaM. GoleijP. GolinelliD. Gomes-NetoM. GoulartA.C. GoyalA. GrayR.J. GrivnaM. GuadieH.A. GuanB. GuarducciG. GuicciardiS. GunawardaneD.A. GuoH. GuptaB. GuptaR. GuptaS. GuptaV.B. GuptaV.K. GutiérrezR.A. HabibzadehF. HachinskiV. HaddadiR. HadeiM. HadiN.R. HaepN. HaileT.G. Haj-MirzaianA. HallB.J. HalwaniR. HameedS. HamiduzzamanM. HammoudA. HanH. HanifiN. HankeyG.J. HannanM.A. HaoJ. HarapanH. HareruH.E. HargonoA. HarliantoN.I. HaroJ.M. HartmanN.N. HasaballahA.I. HasanF. HasaniH. HasanianM. HassanA. HassanS. HassanipourS. HassankhaniH. HassenM.B. HauboldJ. HayS.I. HayatK. HegazyM.I. HeidariG. HeidariM. Heidari-SoureshjaniR. HesamiH. HezamK. HiraikeY. HoffmanH.J. HollaR. HopfK.P. HoritaN. HossainM.M. HossainM.B. HossainS. HosseinzadehH. HosseinzadehM. HostiucS. HuC. HuangJ. HudaM.N. HussainJ. HusseinN.R. HuynhH-H. HwangB-F. IbitoyeS.E. IlaghiM. IlesanmiO.S. IlicI.M. IlicM.D. ImmuranaM. IravanpourF. IslamS.M.S. IsmailF. IsoH. IsolaG. IwagamiM. IwuC.C.D. IyerM. JaanA. JacobL. Jadidi-NiaraghF. JafariM. JafariniaM. JafarzadehA. JahankhaniK. JahanmehrN. JahramiH. JaiswalA. JakovljevicM. JamoraR.D.G. JanaS. JavadiN. JavedS. JaveedS. JayapalS.K. JayaramS. JiangH. JohnsonC.O. JohnsonW.D. JokarM. JonasJ.B. JosephA. JosephN. JoshuaC.E. JürissonM. KabirA. KabirZ. KabitoG.G. KadashettiV. KafiF. KalaniR. KalantarF. KaliyadanF. KamathA. KamathS. KanchanT. KandelA. KandelH. KanmodiK.K. KarajizadehM. KaramiJ. KaranthS.D. KarayeI.M. KarchA. KarimiA. KarimiH. Karimi BehnaghA. KasraeiH. KassebaumN.J. KauppilaJ.H. KaurH. KaurN. KayodeG.A. KazemiF. Keikavoosi-AraniL. KellerC. KeykhaeiM. KhadembashiriM.A. KhaderY.S. KhafaieM.A. KhajuriaH. KhalajiA. KhamesipourF. KhammarniaM. KhanM. KhanM.A.B. KhanY.H. KhanS.M.Z. KhanmohammadiS. KhannaT. KhatabK. KhatatbehH. KhatatbehM.M. KhateriS. KhatibM.N. Khayat KashaniH.R. KhonjiM.S. khorashadizadehF. KhormaliM. KhubchandaniJ. KianS. KimG. KimJ. KimM.S. KimY.J. KimokotiR.W. KisaA. KisaS. KivimäkiM. KochharS. KolahiA-A. KolyK.N. KompaniF. KoroshetzW.J. KosenS. Kourosh AramiM. KoyanagiA. KravchenkoM.A. KrishanK. KrishnamoorthyV. Kuate DefoB. KuddusM.A. KumarA. KumarG.A. KumarM. KumarN. KumsaN.B. KunduS. KurniasariM.D. KusumaD. KuttikkattuA. KyuH.H. La VecchiaC. LadanM.A. LahariyaC. LaksonoT. LalD.K. LallukkaT. LámJ. LamiF.H. LandiresI. LangguthB. LasradoS. LatiefK. LatifinaibinK. LauK.M-M. LaurensM.B. LawalB.K. LeL.K.D. LeT.T.T. LeddaC. LeeM. LeeS. LeeS.W. LeeW-C. LeeY.H. LeonardiM. LerangoT.L. LiM-C. LiW. LigadeV.S. LimS.S. LinehanC. LiuC. LiuJ. LiuW. LoC-H. LoW.D. LoboS.W. LogroscinoG. LopesG. LopukhovP.D. LorenzoviciL. LorkowskiS. LoureiroJ.A. LubindaJ. LucchettiG. Lutzky SauteR. MaZ.F. MabrokM. MachoyM. MadadizadehF. Magdy Abd El RazekM. MaghazachiA.A. MaghbouliN. MahjoubS. MahmoudiM. MajeedA. Malagón-RojasJ.N. Malakan RadE. MalhotraK. MalikA.A. MalikI. MallhiT.H. MaltaD.C. ManilalA. MansouriV. MansourniaM.A. MarasiniB.P. MaratebH.R. MaroufiS.F. Martinez-RagaJ. MartiniS. Martins-MeloF.R. MartorellM. MärzW. MarzoR.R. MassanoJ. MathangasingheY. MathewsE. MaudeR.J. MaugeriA. MaulikP.K. MayeliM. MazaheriM. McAlindenC. McGrathJ.J. MeenaJ.K. MehndirattaM.M. Mendez-LopezM.A.M. MendozaW. Mendoza-CanoO. MenezesR.G. MeratiM. MeretojaA. MerkinA. MershaA.M. MestrovicT. MiT. MiazgowskiT. MichalekI.M. MihretieE.T. MinhL.H.N. MirfakhraieR. MiricaA. MirrakhimovE.M. MirzaeiM. MisganawA. MisraS. MithraP. MizanaB.A. MohamadkhaniA. MohamedN.S. MohammadiE. MohammadiH. MohammadiS. MohammadiS. MohammadshahiM. MohammedM. MohammedS. MohammedS. MohanS. Mojiri-forushaniH. MokaN. MokdadA.H. MolinaroS. MöllerH. MonastaL. MoniruzzamanM. MontazeriF. MoradiM. MoradiY. Moradi-LakehM. MoragaP. MorovatdarN. MorrisonS.D. MosapourA. MosserJ.F. MossialosE. MotaghinejadM. MousaviP. MousaviS.E. MubarikS. MuccioliL. MughalF. MukoroG.D. MulitaA. MulitaF. MusaigwaF. MustafaA. MustafaG. MuthuS. NagarajanA.J. NaghaviP. NaikG.R. NainuF. NairT.S. NajmuldeenH.H.R. NakhostinA.N. NambiG. Namdar AreshtanabH. NargusS. NascimentoB.R. NaserA.Y. NashwanA.J.J. NasooriH. NasreldeinA. NattoZ.S. NaumanJ. NayakB.P. Nazri-PanjakiA. NegareshM. NegashH. NegoiI. NegoiR.I. NegruS.M. NejadghaderiS.A. NematollahiM.H. NesbitO.D. NewtonC.R.J. NguyenD.H. NguyenH.T.H. NguyenH.Q. NguyenN-T.T. NguyenP.T. NguyenV.T. NiaziR.K. NikolouzakisT.K. NiranjanV. NnyanziL.A. NomanE.A. NorooziN. NorrvingB. NoubiapJ.J. Nri-EzediC.A. NtaiosG. Nuńez-SamudioV. NurrikaD. OanceaB. OdetokunI.A. O’DonnellM.J. OgunsakinR.E. OgutaJ.O. OhI-H. Okati-AliabadH. OkekeS.R. OkekunleA.P. OkonjiO.C. OkwuteP.G. OlagunjuA.T. OlaiyaM.T. OlanaM.D. OlatubiM.I. OliveiraG.M.M. OlufadewaI.I. OlusanyaB.O. Omar BaliA. OngS. OnwujekweO.E. OrdakM. OrjiA.U. Ortega-AltamiranoD.V. OsuagwuU.L. OtstavnovN. OtstavnovS.S. OuyahiaA. OwolabiM.O. P AM.P. Pacheco-BarriosK. PadubidriJ.R. PalP.K. PalangeP.N. PalladinoC. PalladinoR. Palma-AlvarezR.F. PanF. PanagiotakosD. Panda-JonasS. PandeyA. PandeyA. PandianJ.D. PangaribuanH.U. PantazopoulosI. PardhanS. ParijaP.P. ParikhR.R. ParkS. ParthasarathiA. PashaeiA. PatelJ. PatilS. PatouliasD. PawarS. PedersiniP. PensatoU. PereiraD.M. PereiraJ. PereiraM.O. PeresM.F.P. PericoN. PernaS. PetcuI-R. Petermann-RochaF.E. PhamH.T. PhillipsM.R. Pinilla-MonsalveG.D. PiradovM.A. PlotnikovE. PoddigheD. PolatB. PoluruR. PondC.D. PoudelG.R. PouraminiA. Pourbagher-ShahriA.M. PourfridoniM. PourtaheriN. PrakashP.Y. PrakashS. PrakashV. PratesE.J.S. PritchettN. PurnobasukiH. QasimN.H. QatteaI. QianG. RadhakrishnanV. RaeeP. RaeisiS.H. RafiqueI. RaggiA. RaghavP.R. RahatiM.M. RahimF. RahimiZ. RahimifardM. RahmanM.O. RahmanM.H.U. RahmanM. RahmanM.A. RahmaniA.M. RahmaniS. Rahmani YoushanloueiH. RahmatiM. Raj MoolamballyS. Rajabpour-SanatiA. RamadanH. RamasamyS.K. RamasubramaniP. RamazanuS. RancicN. RaoI.R. RaoS.J. RapakaD. RashediV. RashidA.M. RashidiM-M. Rashidi AlavijehM. Rasouli-SaravaniA. RawafS. RazoC. RedwanE.M.M. Rekabi BanaA. RemuzziG. RezaeiN. RezaeiN. RezaeiN. RezaeianM. RheeT.G. RiadA. RobinsonS.R. RodriguesM. RodriguezJ.A.B. RoeverL. RogowskiE.L.B. RomoliM. RonfaniL. RoyP. Roy PramanikK. RubagottiE. RuizM.A. RussT.C. S SunnerhagenK. SaadA.M.A. SaadatianZ. SaberK. SaberiKamarposhtiM. SaccoS. SaddikB. SadeghiE. SadeghianS. SaeedU. SaeedU. SafdarianM. SafiS.Z. SagarR. SagoeD. Saheb Sharif-AskariF. Saheb Sharif-AskariN. SahebkarA. SahooS.S. SahraianM.A. SajediS.A. SakshaugJ.W. SalehM.A. Salehi OmranH. SalemM.R. SalimiS. Samadi KafilH. SamadzadehS. SamargandyS. SamodraY.L. SamuelV.P. SamyA.M. SanadgolN. SanjeevR.K. SanmarchiF. SantomauroD.F. SantriI.N. Santric-MilicevicM.M. SaravananA. SarveazadA. SatpathyM. SaylanM. SayyahM. ScarmeasN. SchlaichM.P. SchuermansA. SchwarzingerM. SchwebelD.C. SelvarajS. SendekieA.K. SenguptaP. SenthilkumaranS. SerbanD. SergindoM.T. SethiY. SeyedAlinaghiS.A. SeylaniA. ShabaniM. ShabanyM. ShafieM. ShahabiS. ShahbandiA. ShahidS. Shahraki-SanaviF. ShahsavariH.R. ShahwanM.J. ShaikhM.A. ShajiK.S. ShamS. ShamaA.T.T. ShamimM.A. Shams-BeyranvandM. ShamsiM.A. ShanawazM. SharathM. SharfaeiS. SharifanA. SharmaM. SharmaR. ShashamoB.B. ShayanM. SheikhiR.A. ShekharS. ShenJ. ShenoyS.M. ShettyP.H. ShiferawD.S. ShigematsuM. ShiriR. ShittuA. ShivakumarK.M. ShokriF. ShoolS. ShorofiS.A. ShresthaS. SiankamT.A.B. SiddigE.E. SigfusdottirI.D. SilvaJ.P. SilvaL.M.L.R. SinaeiE. SinghB.B. SinghG. SinghP. SinghS. SirotaS.B. SivakumarS. SohagA.A.M. SolankiR. SoleimaniH. SolikhahS. SolomonY. SolomonY. SongS. SongY. SotoudehH. SpartalisM. StarkB.A. StarnesJ.R. StarodubovaA.V. SteinD.J. SteinerT.J. StovnerL.J. SulemanM. SuliankatchiA.R. SultanaA. SunJ. SunkersingD. SunnyA. SusiantiH. SwainC.K. SzetoM.D. Tabarés-SeisdedosR. TabatabaeiS.M. TabatabaiS. TabishM. TaheriM. TahvildariA. TajbakhshA. TampaM. TamuziJ.J.L.L. TanK-K. TangH. TarekeM. TariganI.U. TatN.Y. TatV.Y. Tavakoli OliaeeR. TavangarS.M. TavasolA. TeferaY.M. Tehrani-BanihashemiA. TemesgenW.A. TemsahM-H. TeramotoM. TesfayeA.H. TesfayeE.G. TeslerR. ThakaliO. ThangarajuP. ThapaR. ThaparR. ThomasN.K. ThriftA.G. TicoaluJ.H.V. TillawiT. ToghroliR. TonelliM. Tovani-PaloneM.R. TrainiE. TranN.M. TranN-H. TranP.V. TromansS.J. TruelsenT.C. TruyenT.T.T.T. TsatsakisA. TsegayG.M. TsermpiniE.E. TualekaA.R. TufaD.G. UbahC.S. UdoakangA.J. UlhaqI. UmairM. UmakanthanS. UmapathiK.K. UnimB. UnnikrishnanB. VaithinathanA.G. VakilianA. Valadan TahbazS. ValizadehR. Van den EyndeJ. VartP. VarthyaS.B. VasankariT.J. VaziriS. VellingiriB. VenketasubramanianN. VerrasG-I. VervoortD. VillafańeJ.H. VillaniL. Vinueza VelozA.F. ViskadourouM. VladimirovS.K. VlassovV. VolovatS.R. VuL.T. VujcicI.S. WagayeB. WaheedY. WahoodW. WaldeM.T. WangF. WangS. WangY. WangY-P. WaqasM. WarisA. WeerakoonK.G. WeintraubR.G. WeldemariamA.H. WestermanR. WhisnantJ.L. WickramasingheD.P. WickramasingheN.D. WillekensB. WilnerL.B. WinklerA.S. WolfeC.D.A. WuA-M. Wulf HansonS. XuS. XuX. YadollahpourA. YaghoubiS. YahyaG. YamagishiK. YangL. YanoY. YaoY. YehualashetS.S. YeshanehA. YesiltepeM. YiS. YiğitA. YiğitV. YonD.K. YonemotoN. YouY. YounisM.Z. YuC. YusufH. ZadeyS. ZahediM. ZakhamF. ZakiN. ZaliA. ZamagniG. ZandR. ZandiehG.G.Z. ZangiabadianM. ZarghamiA. ZastrozhinM.S. ZeariyaM.G.M. ZegeyeZ.B. ZeukengF. ZhaiC. ZhangC. ZhangH. ZhangY. ZhangZ-J. ZhaoH. ZhaoY. ZhengP. ZhouH. ZhuB. ZhumagaliulyA. ZielińskaM. ZikargY.T. ZoladlM. MurrayC.J.L. OngK.L. FeiginV.L. VosT. DuaT. GBD 2021 Nervous System Disorders Collaborators Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021.Lancet Neurol.202423434438110.1016/S1474‑4422(24)00038‑338493795
     [Google Scholar]
  2. RajanK.B. WeuveJ. BarnesL.L. McAninchE.A. WilsonR.S. EvansD.A. Population estimate of people with clinical Alzheimer’s disease and mild cognitive impairment in the United States (2020–2060).Alzheimers Dement.202117121966197510.1002/alz.1236234043283
     [Google Scholar]
  3. NicholsE. SteinmetzJ.D. VollsetS.E. FukutakiK. ChalekJ. Abd-AllahF. AbdoliA. AbualhasanA. Abu-GharbiehE. AkramT.T. Al HamadH. AlahdabF. AlaneziF.M. AlipourV. AlmustanyirS. AmuH. AnsariI. ArablooJ. AshrafT. Astell-BurtT. AyanoG. Ayuso-MateosJ.L. BaigA.A. BarnettA. BarrowA. BauneB.T. BéjotY. BezabheW.M.M. BezabihY.M. BhagavathulaA.S. BhaskarS. BhattacharyyaK. BijaniA. BiswasA. BollaS.R. BoloorA. BrayneC. BrennerH. BurkartK. BurnsR.A. CámeraL.A. CaoC. CarvalhoF. Castro-de-AraujoL.F.S. Catalá-LópezF. CerinE. ChavanP.P. CherbuinN. ChuD-T. CostaV.M. CoutoR.A.S. DadrasO. DaiX. DandonaL. DandonaR. De la Cruz-GóngoraV. DhamnetiyaD. Dias da SilvaD. DiazD. DouiriA. EdvardssonD. EkholuenetaleM. El SayedI. El-JaafaryS.I. EskandariK. EskandariehS. EsmaeilnejadS. FaresJ. FaroA. FarooqueU. FeiginV.L. FengX. FereshtehnejadS-M. FernandesE. FerraraP. FilipI. FillitH. FischerF. GaidhaneS. GalluzzoL. GhashghaeeA. GhithN. GialluisiA. GilaniS.A. GlavanI-R. GnedovskayaE.V. GolechhaM. GuptaR. GuptaV.B. GuptaV.K. HaiderM.R. HallB.J. HamidiS. HanifA. HankeyG.J. HaqueS. HartonoR.K. HasaballahA.I. HasanM.T. HassanA. HayS.I. HayatK. HegazyM.I. HeidariG. Heidari-SoureshjaniR. HerteliuC. HousehM. HussainR. HwangB-F. IacovielloL. IavicoliI. IlesanmiO.S. IlicI.M. IlicM.D. IrvaniS.S.N. IsoH. IwagamiM. JabbarinejadR. JacobL. JainV. JayapalS.K. JayawardenaR. JhaR.P. JonasJ.B. JosephN. KalaniR. KandelA. KandelH. KarchA. KasaA.S. KassieG.M. KeshavarzP. KhanM.A.B. KhatibM.N. KhojaT.A.M. KhubchandaniJ. KimM.S. KimY.J. KisaA. KisaS. KivimäkiM. KoroshetzW.J. KoyanagiA. KumarG.A. KumarM. LakH.M. LeonardiM. LiB. LimS.S. LiuX. LiuY. LogroscinoG. LorkowskiS. LucchettiG. Lutzky SauteR. MagnaniF.G. MalikA.A. MassanoJ. MehndirattaM.M. MenezesR.G. MeretojaA. MohajerB. Mohamed IbrahimN. MohammadY. MohammedA. MokdadA.H. MondelloS. MoniM.A.A. MoniruzzamanM. MossieT.B. NagelG. NaveedM. NayakV.C. Neupane KandelS. NguyenT.H. OanceaB. OtstavnovN. OtstavnovS.S. OwolabiM.O. Panda-JonasS. Pashazadeh KanF. PasovicM. PatelU.K. PathakM. PeresM.F.P. PerianayagamA. PetersonC.B. PhillipsM.R. PinheiroM. PiradovM.A. PondC.D. PotashmanM.H. PottooF.H. PradaS.I. RadfarA. RaggiA. RahimF. RahmanM. RamP. RanasingheP. RawafD.L. RawafS. RezaeiN. RezapourA. RobinsonS.R. RomoliM. RoshandelG. SahathevanR. SahebkarA. SahraianM.A. SathianB. SattinD. SawhneyM. SaylanM. SchiavolinS. SeylaniA. ShaF. ShaikhM.A. ShajiK.S. ShannawazM. ShettyJ.K. ShigematsuM. ShinJ.I. ShiriR. SilvaD.A.S. SilvaJ.P. SilvaR. SinghJ.A. SkryabinV.Y. SkryabinaA.A. SmithA.E. SoshnikovS. SpurlockE.E. SteinD.J. SunJ. Tabarés-SeisdedosR. ThakurB. TimalsinaB. Tovani-PaloneM.R. TranB.X. TsegayeG.W. Valadan TahbazS. ValdezP.R. VenketasubramanianN. VlassovV. VuG.T. VuL.G. WangY-P. WimoA. WinklerA.S. YadavL. Yahyazadeh JabbariS.H. YamagishiK. YangL. YanoY. YonemotoN. YuC. YunusaI. ZadeyS. ZastrozhinM.S. ZastrozhinaA. ZhangZ-J. MurrayC.J.L. VosT. GBD 2019 Dementia Forecasting Collaborators Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019.Lancet Public Health202272e105e12510.1016/S2468‑2667(21)00249‑834998485
     [Google Scholar]
  4. QiT. SongL. GuoY. ChenC. YangJ. From genetic associations to genes: Methods, applications, and challenges.Trends Genet.202440864266710.1016/j.tig.2024.04.00838734482
     [Google Scholar]
  5. SalvadèM. DiLucaM. GardoniF. An update on drug repurposing in Parkinson’s disease: Preclinical and clinical considerations.Biomed. Pharmacother.202518311786210.1016/j.biopha.2025.11786239842271
     [Google Scholar]
  6. ZakiJ.K. TomasikJ. BahnS. IUPHAR review: Drug repurposing in Schizophrenia – An updated review of clinical trials.Pharmacol. Res.202521310763310.1016/j.phrs.2025.10763339884448
     [Google Scholar]
  7. MitevV. Colchicine—the divine medicine against COVID-19.J. Pers. Med.202414775610.3390/jpm1407075639064010
     [Google Scholar]
  8. LuJ. HeY. TerkeltaubR. SunM. RanZ. XuX. WangC. LiX. HuS. XueX. YanF. ZhangH. YinH. ShiY. DalbethN. LiC. Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccination.Ann. Rheum. Dis.20228181189119310.1136/annrheumdis‑2022‑22219935277390
     [Google Scholar]
  9. HuaY. ZhengY. YaoY. JiaR. GeS. ZhuangA. Metformin and cancer hallmarks: Shedding new lights on therapeutic repurposing.J. Transl. Med.202321140310.1186/s12967‑023‑04263‑837344841
     [Google Scholar]
  10. StrafellaV. AttolicoI. CarluccioP. TarantiniF. CurciP. SgherzaN. RizziR. OstuniA. BudaG. Del GiudiceM.L. MarascoV. MeleA. Margiotta-CasaluciG. ValliV.B. MeleG. GermanoC.R. QuintoA.M. PalazzoG. FebboM.A. CiuffredaL. ReddicontoG. Di RenzoN. CimminielloM. AlbanoF. MustoP. Effects of daratumumab on hematopoietic stem cell collection and engraftment in multiple myeloma patients eligible for autologous transplantation: Results of the real-life PRIMULA study comparing bortezomib, thalidomide and dexamethasone (VTd) with VTd plus daratumumab (D-VTd) as induction therapy.Ann. Hematol.2024103104345434710.1007/s00277‑024‑05933‑339168910
     [Google Scholar]
  11. PessettoZ.Y. WeirS.J. SethiG. BrowardM.A. GodwinA.K. Drug repurposing for gastrointestinal stromal tumor.Mol. Cancer Ther.20131271299130910.1158/1535‑7163.MCT‑12‑096823657945
     [Google Scholar]
  12. EmdinC.A. KheraA.V. KathiresanS. Mendelian randomization.JAMA2017318191925192610.1001/jama.2017.1721929164242
     [Google Scholar]
  13. ReayW.R. CairnsM.J. Advancing the use of genome-wide association studies for drug repurposing.Nat. Rev. Genet.2021221065867110.1038/s41576‑021‑00387‑z34302145
     [Google Scholar]
  14. ZhangS. HuX. Pharmaceutical repurposing strategies for metabolic disorders: Insights from mendelian randomization studies.medRxiv202410.1101/2024.03.29.24305070
     [Google Scholar]
  15. DuanQ.Q. WangH. SuW.M. GuX.J. ShenX.F. JiangZ. RenY.L. CaoB. LiG.B. WangY. ChenY.P. TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: Evidence from druggable genome Mendelian randomization and pharmacological verification in vitro.BMC Med.20242219610.1186/s12916‑024‑03314‑138443977
     [Google Scholar]
  16. GiambartolomeiC. Zhenli LiuJ. ZhangW. HaubergM. ShiH. BoocockJ. PickrellJ. JaffeA.E. PasaniucB. RoussosP. CommonMind Consortium A Bayesian framework for multiple trait colocalization from summary association statistics.Bioinformatics201834152538254510.1093/bioinformatics/bty14729579179
     [Google Scholar]
  17. Bulik-SullivanB.K. LohP.R. FinucaneH.K. RipkeS. YangJ. PattersonN. DalyM.J. PriceA.L. NealeB.M. Schizophrenia Working Group of the Psychiatric Genomics Consortium LD Score regression distinguishes confounding from polygenicity in genome-wide association studies.Nat. Genet.201547329129510.1038/ng.321125642630
     [Google Scholar]
  18. WuY. ByrneE.M. ZhengZ. KemperK.E. YengoL. MallettA.J. YangJ. VisscherP.M. WrayN.R. Genome-wide association study of medication-use and associated disease in the UK Biobank.Nat. Commun.2019101189110.1038/s41467‑019‑09572‑531015401
     [Google Scholar]
  19. KurkiM.I. KarjalainenJ. PaltaP. SipiläT.P. KristianssonK. DonnerK.M. ReeveM.P. LaivuoriH. AavikkoM. KaunistoM.A. LoukolaA. LahtelaE. MattssonH. LaihoP. Della Briotta ParoloP. LehistoA.A. KanaiM. MarsN. RämöJ. KiiskinenT. HeyneH.O. VeerapenK. RüegerS. LemmeläS. ZhouW. RuotsalainenS. PärnK. HiekkalinnaT. KoskelainenS. PaajanenT. LlorensV. Gracia-TabuencaJ. SiirtolaH. ReisK. ElnahasA.G. SunB. FoleyC.N. Aalto-SetäläK. AlasooK. ArvasM. AuroK. BiswasS. Bizaki-VallaskangasA. CarpenO. ChenC.Y. DadaO.A. DingZ. EhmM.G. EklundK. FärkkiläM. FinucaneH. GannaA. GhazalA. GrahamR.R. GreenE.M. HakanenA. HautalahtiM. HedmanÅ.K. HiltunenM. HinttalaR. HovattaI. HuX. Huertas-VazquezA. HuilajaL. HunkapillerJ. JacobH. JensenJ.N. JoensuuH. JohnS. JulkunenV. JungM. JunttilaJ. KaarnirantaK. KähönenM. KajanneR. KallioL. KälviäinenR. KaprioJ. KerimovN. KettunenJ. KilpeläinenE. KilpiT. KlingerK. KosmaV.M. KuopioT. KurraV. LaiskT. LaukkanenJ. LawlessN. LiuA. LongerichS. MägiR. MäkeläJ. MäkitieA. MalarstigA. MannermaaA. MaranvilleJ. MatakidouA. MeretojaT. MozaffariS.V. NiemiM.E.K. NiemiM. NiiranenT. O´DonnellC.J. ObeidatM. OkafoG. OllilaH.M. PalomäkiA. PalotieT. PartanenJ. PaulD.S. PelkonenM. PendergrassR.K. PetrovskiS. PitkärantaA. PlattA. PulfordD. PunkkaE. PussinenP. RaghavanN. RahimovF. RajpalD. RenaudN.A. Riley-GillisB. RodosthenousR. SaarentausE. SalminenA. SalminenE. SalomaaV. SchleutkerJ. SerpiR. ShenH. SiegelR. SilanderK. SiltanenS. SoiniS. SoininenH. SulJ.H. TachmazidouI. TasanenK. TienariP. Toppila-SalmiS. TukiainenT. TuomiT. TurunenJ.A. UlirschJ.C. VauraF. VirolainenP. WaringJ. WaterworthD. YangR. NelisM. ReigoA. MetspaluA. MilaniL. EskoT. FoxC. HavulinnaA.S. PerolaM. RipattiS. JalankoA. LaitinenT. MäkeläT.P. PlengeR. McCarthyM. RunzH. DalyM.J. PalotieA. FinnGen FinnGen provides genetic insights from a well-phenotyped isolated population.Nature2023613794450851810.1038/s41586‑022‑05473‑836653562
     [Google Scholar]
  20. SkrivankovaV.W. RichmondR.C. WoolfB.A.R. YarmolinskyJ. DaviesN.M. SwansonS.A. VanderWeeleT.J. HigginsJ.P.T. TimpsonN.J. DimouN. LangenbergC. GolubR.M. LoderE.W. GalloV. Tybjaerg-HansenA. Davey SmithG. EggerM. RichardsJ.B. Strengthening the reporting of observational studies in epidemiology using mendelian randomization.JAMA2021326161614162110.1001/jama.2021.1823634698778
     [Google Scholar]
  21. HaycockP.C. BorgesM.C. BurrowsK. LemaitreR.N. HarrisonS. BurgessS. ChangX. WestraJ. KhankariN.K. TsilidisK.K. GauntT. HemaniG. ZhengJ. TruongT. O’MaraT.A. SpurdleA.B. LawM.H. SlagerS.L. BirmannB.M. Saberi HosnijehF. MariosaD. AmosC.I. HungR.J. ZhengW. GunterM.J. Davey SmithG. ReltonC. MartinR.M. TintleN. PetersU. RiceT. ChengI. JenkinsM. GallingerS. CornishA.J. SudA. VijayakrishnanJ. WrenschM. JohanssonM. NormanA.D. KleinA. Clay-GilmourA. FrankeA. Ardisson KoratA.V. WheelerB. NilssonB. SmithC. HengC-K. SongC. RiadiD. ClausE.B. EllinghausE. OstroumovaE. Hosnijeh de VathaireF. CugliariG. MatulloG. NgI.O-L. CerhanJ.R. PassowJ.E. FooJ.N. HanJ. LiuJ. Barnholtz-SloanJ. SchildkrautJ.M. MarisJ. WiemelsJ.L. HemminkiK. YangK. KiemeneyL.A. WuL. AmundadottirL. SternM-H. BoutronM-C. IlesM.M. PurdueM.P. StanullaM. BondyM. GaudetM. LenhaM. CampN.J. ShamP.C. GuénelP. BrennanP. TaylorP.R. GharahkhaniP. OstromQ. Stolzenberg-SolomonR. DorajooR. HoulstonR. JenkinsR.B. DiskinS. BerndtS.I. TsavachidisS. EnrothS. ChannockS.J. HarrisonT. GaleslootT. GyllenstenU. JosephV. ShiY. YangW. LinY. Van Den EedenS.K. Fatty Acids in Cancer Mendelian Randomization Collaboration Design and quality control of large-scale two-sample Mendelian randomization studies.Int. J. Epidemiol.20235251498152110.1093/ije/dyad01838587501
     [Google Scholar]
  22. KamatM.A. BlackshawJ.A. YoungR. SurendranP. BurgessS. DaneshJ. ButterworthA.S. StaleyJ.R. PhenoScanner V2: An expanded tool for searching human genotype–phenotype associations.Bioinformatics201935224851485310.1093/bioinformatics/btz46931233103
     [Google Scholar]
  23. BurgessS. ThompsonS.G. CRP CHD Genetics Collaboration Avoiding bias from weak instruments in Mendelian randomization studies.Int. J. Epidemiol.201140375576410.1093/ije/dyr03621414999
     [Google Scholar]
  24. LarssonS.C. ButterworthA.S. BurgessS. Mendelian randomization for cardiovascular diseases: Principles and applications.Eur. Heart J.202344474913492410.1093/eurheartj/ehad73637935836
     [Google Scholar]
  25. CohenJ.F. ChalumeauM. CohenR. KorevaarD.A. KhoshnoodB. BossuytP.M.M. Cochran’s Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracy.J. Clin. Epidemiol.201568329930610.1016/j.jclinepi.2014.09.00525441698
     [Google Scholar]
  26. DaiJ.Y. PetersU. WangX. KocarnikJ. Chang-ClaudeJ. SlatteryM.L. ChanA. LemireM. BerndtS.I. CaseyG. SongM. JenkinsM.A. BrennerH. ThriftA.P. WhiteE. HsuL. Diagnostics for pleiotropy in mendelian randomization studies: Global and individual tests for direct effects.Am. J. Epidemiol.2018187122672268010.1093/aje/kwy17730188971
     [Google Scholar]
  27. WangG. SarkarA. CarbonettoP. StephensM. A simple new approach to variable selection in regression, with application to genetic fine mapping.J. R. Stat. Soc. Series B Stat. Methodol.20208251273130010.1111/rssb.1238837220626
     [Google Scholar]
  28. JaliA.M. BanjiD. BanjiO.J.F. HurubiK.Y. TawhariF.Y. AlameerA.A. DohalA.S. ZanqotiR.A. Navigating preclinical models and medications for peripheral neuropathy: A review.Pharmaceuticals2024178101010.3390/ph1708101039204115
     [Google Scholar]
  29. EscribáP.V. Gil-AgudoÁ.M. Vidal SamsóJ. Sánchez-RayaJ. Salvador-de la BarreraS. Soto-LeónV. León-ÁlvarezN. Méndez FerrerB. Membrilla-MesaM.D. Redondo GalánC. Benito-PenalvaJ. Montoto-MarquésA. MedelR.J. Palazón GarcíaR. GutiérrezH.F. MirallesM. TorresM. Nieto-LibreroA.B. GarcíaM.D. GómezC. JimenoD. OlivieroA. Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury.Spinal Cord202462845446710.1038/s41393‑024‑01006‑438898145
     [Google Scholar]
  30. LiY. LongX. LuoF. ZhangJ. SunS. DuP. YangH. ChenQ. ShengC. BaiX. Efficacy and safety of gabapentinoids for acute herpes zoster neuralgia.Clin. J. Pain202440744044610.1097/AJP.000000000000121838651606
     [Google Scholar]
  31. MooreA. BidondeJ. Withdrawn as duplicate: Transarterial periarticular embolization (TAPE) in checkpoint-inhibitor-associated arthritis-a novel treatment strategy.Rheumatology20256431553156010.1093/rheumatology/keae707
     [Google Scholar]
  32. MianM.U. AfzalM. ButtA.A. IjazM. KhalilK. AbbasiM. FatimaM. AsifM. NadeemS. JhaS. PanjiyarB.K. Neuropharmacology of neuropathic pain: A systematic review.Cureus2024169e6902810.7759/cureus.6902839385859
     [Google Scholar]
  33. HongJ.S.W. AtkinsonL.Z. Al-JuffaliN. AwadA. GeddesJ.R. TunbridgeE.M. HarrisonP.J. CiprianiA. Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale.Mol. Psychiatry20222731339134910.1038/s41380‑021‑01386‑634819636
     [Google Scholar]
  34. MayoralV. GalvezR. FerrándizM. MiguénsV.X. Cordero-GarcíaC. AlcántaraM.A. PérezC. Pérez-PáramoM. Pregabalin vs. gabapentin in the treatment of neuropathic pain: A comprehensive systematic review and meta-analysis of effectiveness and safety.Front. Pain Res.20255151359710.3389/fpain.2024.151359739839199
     [Google Scholar]
  35. FeltnerD.E. CrockattJ.G. DubovskyS.J. CohnC.K. ShrivastavaR.K. TargumS.D. Liu-DumawM. CarterC.M. PandeA.C. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder.J. Clin. Psychopharmacol.200323324024910.1097/01.jcp.0000084032.22282.ff12826986
     [Google Scholar]
  36. BaldwinD.S. AjelK. Role of pregabalin in the treatment of generalized anxiety disorder.Neuropsychiatr. Dis. Treat.20073218519110.2147/nedt.2007.3.2.18519300552
     [Google Scholar]
  37. FramptonJ.E. Pregabalin: A review of its use in adults with generalized anxiety disorder.CNS Drugs201428983585410.1007/s40263‑014‑0192‑025149863
     [Google Scholar]
  38. CalandreE.P. Rico-VillademorosF. SlimM. Alpha 2 delta ligands, gabapentin, pregabalin and mirogabalin: A review of their clinical pharmacology and therapeutic use.Expert Rev. Neurother.201616111263127710.1080/14737175.2016.120276427345098
     [Google Scholar]
  39. GuoS.J. ShiY.Q. ZhengY.N. LiuH. ZhengY.L. The voltage-gated calcium channel α2δ subunit in neuropathic pain.Mol. Neurobiol.20256222561257210.1007/s12035‑024‑04424‑w39136907
     [Google Scholar]
  40. MatsumotoD. UshioS. WadaY. NodaY. EsumiS. IzushiY. KitamuraY. SendoT. Bumetanide prevents diazepam-modified anxiety-like behavior in lipopolysaccharide-treated mice.Eur. J. Pharmacol.202190417419510.1016/j.ejphar.2021.17419534004209
     [Google Scholar]
  41. KrystalA.D. SutherlandJ. HochmanD.W. Loop diuretics have anxiolytic effects in rat models of conditioned anxiety.PLoS One201274e3541710.1371/journal.pone.003541722514741
     [Google Scholar]
  42. KourdougliN. NomuraT. The NKCC1 inhibitor bumetanide restores cortical feedforward inhibition and lessens sensory hypersensitivity in early postnatal fragile X mice.Biol. Psychiatry202438950809
     [Google Scholar]
  43. TengelmannC. JoosS. KaußnerY. MalzahnU. LundenL. KlugA. HäuslerK.G. EscalesC. MaetzlerW. HügenK. ZolkO. HeuschmannP.U. FörsterC. KaduszkiewiczH. GágyorI. Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) – protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb).BMC Infect. Dis.20242415610.1186/s12879‑023‑08925‑238184567
     [Google Scholar]
  44. MöhlmannJ.E. EzzafzafiS. LindemansC.A. JansenM.H.A. NierkensS. HuitemaA.D.R. van LuinM. Pharmacokinetics and pharmacodynamics of systemic corticosteroids in autoimmune and inflammatory diseases: A review of current evidence.Clin. Pharmacokinet.20246391251127010.1007/s40262‑024‑01419‑739264575
     [Google Scholar]
  45. LeggeA.C. HanlyJ.G. Recent advances in the diagnosis and management of neuropsychiatric lupus.Nat. Rev. Rheumatol.2024201171272810.1038/s41584‑024‑01163‑z39358609
     [Google Scholar]
  46. EkundayoB.E. AdewaleO.B. ObafemiB.A. AfolabiO.B. ObafemiT.O. Management of Alzheimer’s disease and related neurotoxic pathologies: Role of thiamine, pyridoxine and cobalamin.Eur. J. Pharmacol.202498217695810.1016/j.ejphar.2024.17695839209095
     [Google Scholar]
  47. KumarR.R. SinghL. ThakurA. SinghS. KumarB. Role of vitamins in neurodegenerative diseases: A review.CNS Neurol. Disord. Drug Targets202221976677310.2174/187152732066621111912215034802410
     [Google Scholar]
  48. HusnM. AminZ. AliY. KanwalL. SabirK. ShahS.A. ShahS.F. Neuroprotective effects of vitamin B1 on memory impairment and suppression of pro-inflammatory cytokines in traumatic brain injury.Metab. Brain Dis.20233862175218410.1007/s11011‑023‑01245‑z37314619
     [Google Scholar]
  49. Ortigoza-EscobarJ.D. Molero-LuisM. AriasA. Martí-SánchezL. Rodriguez-PomboP. ArtuchR. Pérez-DueñasB. Treatment of genetic defects of thiamine transport and metabolism.Expert Rev. Neurother.201616775576310.1080/14737175.2016.118756227191787
     [Google Scholar]
  50. RamamoorthyK. YoshimuraR. Al-JuburiS. AnandamK.Y. KapadiaR. AlachkarA. AbbottG.W. SaidH.M. Alzheimer’s disease is associated with disruption in thiamin transport physiology: A potential role for neuroinflammation.Neurobiol. Dis.202217110579910.1016/j.nbd.2022.10579935750148
     [Google Scholar]
  51. TapiasV. JainuddinS. AhujaM. StackC. ElipenahliC. VignisseJ. GergesM. StarkovaN. XuH. StarkovA.A. BettendorffL. HushpulianD.M. SmirnovaN.A. GazaryanI.G. KaideryN.A. WakadeS. CalingasanN.Y. ThomasB. GibsonG.E. DumontM. BealM.F. Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy.Hum. Mol. Genet.201827162874289210.1093/hmg/ddy20129860433
     [Google Scholar]
  52. KarachaliouC.E. LivaniouE. Biotin homeostasis and human disorders: Recent findings and perspectives.Int. J. Mol. Sci.20242512657810.3390/ijms2512657838928282
     [Google Scholar]
  53. ChuP. MiocJ. O’DonovanP. HenryO. Clinical efficacy and safety of treatments for exocrine pancreatic insufficiency: A systematic literature review.Digestion20251061456110.1159/00054132639299226
     [Google Scholar]
  54. GaweyB.J. MarsR.A. KashyapP.C. The role of the gut microbiome in disorders of gut–brain interaction.FEBS J.202529261357137710.1111/febs.1720038922780
     [Google Scholar]
  55. KhedpandeN. BarveK. Role of gut dysbiosis in drug-resistant epilepsy: Pathogenesis and available therapeutic strategies.Brain Res.2025185014938510.1016/j.brainres.2024.14938539643107
     [Google Scholar]
  56. YangW. CuiH. WangC. WangX. YanC. ChengW. A review of the pathogenesis of epilepsy based on the microbiota-gut-brain-axis theory.Front. Mol. Neurosci.202417145478010.3389/fnmol.2024.145478039421261
     [Google Scholar]
  57. ZhangR. DingN. FengX. LiaoW. The gut microbiome, immune modulation, and cognitive decline: Insights on the gut-brain axis.Front. Immunol.202516152995810.3389/fimmu.2025.152995839911400
     [Google Scholar]
  58. TsikisS.T. FligorS.C. SecorJ.D. YuL.J. PanA. MitchellP.D. LoringG. FirstE. NedderA.P. GrammerR.M. PattisonB. GuraK.M. PuderM. An in-line digestive cartridge increases enteral fat and vitamin absorption in a porcine model of short bowel syndrome.Clin. Nutr.20224151093110110.1016/j.clnu.2022.03.02635413571
     [Google Scholar]
  59. SourbronJ. AuvinS. Cabral-LimL. DevlinA. DluglosD. HosnyH. MarsonT. MeadorK.J. PatelA.A. PenellP.B. RineyK. TrinkaE. WiebeS. LagaeL. Vitamin D prophylaxis in persons with epilepsy?Epilepsia20246592567257910.1111/epi.1804639494692
     [Google Scholar]
  60. ZongJ. YangY. WangH. ZhangH. YangX. YangX. The two-directional prospective association between inflammatory bowel disease and neurodegenerative disorders: A systematic review and meta-analysis based on longitudinal studies.Front. Immunol.202415132590810.3389/fimmu.2024.132590838720896
     [Google Scholar]
  61. StovicekJ. LiskovaP. LisyJ. HlavaS. KeilR. Crohn’s disease: Is there a place for neurological screening?Scand. J. Gastroenterol.201449217317610.3109/00365521.2013.86735824299027
     [Google Scholar]
  62. McCoubreyL.E. SeegobinN. SangfuangN. MoensF. DuyvejonckH. DeclerckE. DierickA. MarzoratiM. BasitA.W. The colon targeting efficacies of mesalazine medications and their impacts on the gut microbiome.J. Control. Release202436963064110.1016/j.jconrel.2024.04.01638599548
     [Google Scholar]
  63. YangY. MuscoH. Simpson-YapS. ZhuZ. WangY. LinX. ZhangJ. TaylorB. GrattenJ. ZhouY. Investigating the shared genetic architecture between multiple sclerosis and inflammatory bowel diseases.Nat. Commun.2021121564110.1038/s41467‑021‑25768‑034561436
     [Google Scholar]
  64. CapiM. CurtoM. LionettoL. de AndrésF. GentileG. NegroA. MartellettiP. Eletriptan in the management of acute migraine: An update on the evidence for efficacy, safety, and consistent response.Ther. Adv. Neurol. Disord.20169541442310.1177/175628561665061927582896
     [Google Scholar]
  65. CapodannoD. MehranR. KrucoffM.W. BaberU. BhattD.L. CapranzanoP. ColletJ.P. CuissetT. De LucaG. De LucaL. FarbA. FranchiF. GibsonC.M. HahnJ.Y. HongM.K. JamesS. KastratiA. KimuraT. LemosP.A. LopesR.D. MageeA. MatsumuraR. MochizukiS. O’DonoghueM.L. PereiraN.L. RaoS.V. RolliniF. ShiraiY. SibbingD. SmitsP.C. StegP.G. StoreyR.F. ten BergJ. ValgimigliM. VranckxP. WatanabeH. WindeckerS. SerruysP.W. YehR.W. MoriceM.C. AngiolilloD.J. Defining strategies of modulation of antiplatelet therapy in patients with coronary artery disease: A consensus document from the academic research consortium.Circulation2023147251933194410.1161/CIRCULATIONAHA.123.06447337335828
     [Google Scholar]
  66. KocaogluI. GökaslanS. KaragözA. SahinD. UcarÖ. AydogduS. Zolmitriptan-induced acute myocardial infarction.Cardiol. J.2012191767810.5603/CJ.2012.001122298171
     [Google Scholar]
  67. KarlssonW.K. OstinelliE.G. ZhuangZ.A. KokotiL. ChristensenR.H. Al-KhazaliH.M. DeligianniC.I. TomlinsonA. AshinaH. Ruiz de la TorreE. DienerH.C. CiprianiA. AshinaM. Comparative effects of drug interventions for the acute management of migraine episodes in adults: Systematic review and network meta-analysis.BMJ2024386e08010710.1136/bmj‑2024‑08010739293828
     [Google Scholar]
/content/journals/cn/10.2174/011570159X368382250527073353
Loading
Mendelian Randomization Uncovers Potential Repurposable Medications for Neuropsychiatric Disorders
Curr. Neuropharmacol. 24, 241 (2026); https://doi.org/10.2174/011570159X368382250527073353
/content/journals/cn/10.2174/011570159X368382250527073353
/content/journals/cn/10.2174/011570159X368382250527073353
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): causal relationships; Drug repurposing; genetic associations; mendelian randomization; neuropsychiatric disorders; traditional pharmacotherapies

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test